Free Trial
NASDAQ:BHST

BioHarvest Sciences (BHST) Stock Price, News & Analysis

BioHarvest Sciences logo
$6.10 -0.14 (-2.24%)
As of 05/21/2025 03:59 PM Eastern

About BioHarvest Sciences Stock (NASDAQ:BHST)

Key Stats

Today's Range
$6.10
$6.44
50-Day Range
$5.25
$6.75
52-Week Range
$6.10
$7.38
Volume
16,166 shs
Average Volume
17,429 shs
Market Capitalization
$100.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67
Consensus Rating
Buy

Company Overview

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Receive BHST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter.

BHST Stock News Headlines

HC Wainwright Analysts Reduce Earnings Estimates for BHST
Banks aren’t ready for this altcoin—are you?
Bitcoin Just Made Headlines — Here’s Where I’m Putting My Money Next There's a little-known crypto project sitting right in the sweet spot of all these trends and based on what I'm seeing — it could run even harder than BTC.
BioHarvest Sciences Q1 revenue jumps on VINIA growth
See More Headlines

BHST Stock Analysis - Frequently Asked Questions

BioHarvest Sciences' stock was trading at $6.18 at the start of the year. Since then, BHST stock has decreased by 1.3% and is now trading at $6.10.
View the best growth stocks for 2025 here
.

BioHarvest Sciences Inc. (NASDAQ:BHST) posted its quarterly earnings results on Thursday, May, 15th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.02. The business earned $7.64 million during the quarter, compared to analysts' expectations of $8.93 million.
Read the conference call transcript
.

BioHarvest Sciences' top institutional investors include Magnus Financial Group LLC (0.44%) and True North Advisors LLC (0.27%).

Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
5/21/2025
Next Earnings (Estimated)
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BHST
Previous Symbol
NASDAQ:BHST
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.67
High Stock Price Target
$15.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+124.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-12,560,000.00
Pretax Margin
-76.65%

Debt

Sales & Book Value

Annual Sales
$27.70 million
Price / Cash Flow
N/A
Book Value
($1.08) per share
Price / Book
-5.65

Miscellaneous

Free Float
N/A
Market Cap
$100.19 million
Optionable
N/A
Beta
0.80
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:BHST) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners